SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-026954
Filing Date
2022-11-10
Accepted
2022-11-10 16:57:05
Documents
46
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ctdh20220930_10q.htm   iXBRL 10-Q 694125
2 EXHIBIT 31.1 ex_444041.htm EX-31.1 12524
3 EXHIBIT 31.2 ex_444042.htm EX-31.2 12615
4 EXHIBIT 32.1 ex_444043.htm EX-32.1 5066
5 EXHIBIT 32.2 ex_444044.htm EX-32.2 5088
  Complete submission text file 0001437749-22-026954.txt   3572349

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20220930.xsd EX-101.SCH 32854
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctdh-20220930_cal.xml EX-101.CAL 28927
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20220930_def.xml EX-101.DEF 253470
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20220930_lab.xml EX-101.LAB 217212
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20220930_pre.xml EX-101.PRE 266979
40 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20220930_10q_htm.xml XML 437406
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39780 | Film No.: 221378232
SIC: 2860 Industrial Organic Chemicals